Sign in
Taking people in United StatesNo phase

Education and support program for people with advanced kidney disease and high blood pressure

Tests education and support for hospitalized adults with advanced kidney disease.

Key facts

Who runs it
University of Chicago
Where
Chicago, United StatesSee the site
Trial code
Registry title
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
Status
Recruiting
People taking part
180 people, planned
Started
4 Sept 2024
Planned end
30 Jun 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • In-Person Patient Education
  • Commitment to Change
  • Blood pressure monitoring
  • Written Patient Education
  • Text-based reinforcement for CKD self-management
  • Community-based education session, reinforcement for self-management
  • Text-based reinforcement for general health self-management
Record updated
14 November 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for Black or African American adults with advanced chronic kidney disease who are in the hospital at the University of Chicago and expected to stay more than 48 hours.

Age
Over 18 and under 70 years.
Sex
All sexes can join.
Disease stage
Advanced chronic kidney disease: Stage 3B or above, or eGFR<45 during the hospital stay and in earlier medical visits.
Biomarker or test result
eGFR<45 during admission and in previous medical encounters.

Main reasons for not taking part

  • Does not speak English
  • Cannot communicate because of current medical condition
  • Cannot give consent because of mental status
  • Expected hospital stay less than 24 hours
  • Currently in the ICU

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Patients over the age of 18 and under 70
  • Admitted to the University of Chicago inpatient general medicine service
  • Likely hospital stay greater than 48 hours
  • Diagnosis of advanced CKD (Stage 3B or above, as determine by problem list, ICD- 10 codes or eGFR<45 during admission and from previous medical encounters)
  • Self-identify as Black or African American

Who cannot take part

  • Non-English speaking
  • Unable to communicate due to current medical status
  • Unable to consent due to mental status
  • Expected hospital stay less than 24 hour
  • Current admission in ICU

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where in United States

  • University of Chicago Medical CenterChicago, United StatesContact: Milda Saunders, MDTaking people

About the trial

What the trial wants to find out

Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention that identifies hospitalized African Americans with advanced chronic kidney disease (CKD) and provides them with hospital- and community-based education, navigation and self-management support. Participants will be randomized to the iPREP-RRT intervention versus enhanced usual care.

The 2 groups in the trial

  • Intensive Intervention (iPREP RRT)Treatment being tested

    The intervention is administered by a patient educator (PE), a culturally concordant health educator. S/he will review the CKD and RRT education materials on a tablet device with the participant, answer any questions they have, and using motivational interviewing techniques get a commitment for future action. The participant and the patient educator will work together to decide on potential CKD self-management and RRT options and/or next steps. The PE will teach the participant how to use the home blood pressure monitor and will leave it with the participant. The patient educator will check in with the participant through text messages and follow-up phone calls.

    Treatment: In-Person Patient Education, Commitment to Change, Blood pressure monitoring, Text-based reinforcement for CKD self-management, and Community-based education session, reinforcement for self-management

  • Enhanced Usual CarePlacebo, for comparison

    The enhanced usual care is administered by a patient educator (PE), a culturally concordant health educator. The PE will drop off written general health education materials. The patient educator will check in with the participant through text messages.

    Treatment: Written Patient Education and Text-based reinforcement for general health self-management

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
Plain-language title
Education and support program for people with advanced kidney disease and high blood pressureGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06397456, who can take part
Record updated
14 November 2025